These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37667412)

  • 1. Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease.
    Tosun D; Yardibi O; Benzinger TLS; Kukull WA; Masters CL; Perrin RJ; Weiner MW; Simen A; Schwarz AJ;
    Alzheimers Dement; 2024 Jan; 20(1):421-436. PubMed ID: 37667412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology.
    Torso M; Ridgway GR; Valotti M; Hardingham I; Chance SA; ;
    Alzheimers Res Ther; 2023 Oct; 15(1):165. PubMed ID: 37794477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
    Dai DL; Tropea TF; Robinson JL; Suh E; Hurtig H; Weintraub D; Van Deerlin V; Lee EB; Trojanowski JQ; Chen-Plotkin AS
    Acta Neuropathol; 2020 Oct; 140(4):449-461. PubMed ID: 32749525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma biomarkers for Alzheimer's Disease in relation to neuropathology and cognitive change.
    Smirnov DS; Ashton NJ; Blennow K; Zetterberg H; Simrén J; Lantero-Rodriguez J; Karikari TK; Hiniker A; Rissman RA; Salmon DP; Galasko D
    Acta Neuropathol; 2022 Apr; 143(4):487-503. PubMed ID: 35195758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development and convergence of co-pathologies in Alzheimer's disease.
    Robinson JL; Richardson H; Xie SX; Suh E; Van Deerlin VM; Alfaro B; Loh N; Porras-Paniagua M; Nirschl JJ; Wolk D; Lee VM; Lee EB; Trojanowski JQ
    Brain; 2021 Apr; 144(3):953-962. PubMed ID: 33449993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    Ryman SG; Yutsis M; Tian L; Henderson VW; Montine TJ; Salmon DP; Galasko D; Poston KL
    J Alzheimers Dis; 2021; 80(3):1243-1256. PubMed ID: 33646154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease.
    Uemura MT; Robinson JL; Cousins KAQ; Tropea TF; Kargilis DC; McBride JD; Suh E; Xie SX; Xu Y; Porta S; Uemura N; Van Deerlin VM; Wolk DA; Irwin DJ; Brunden KR; Lee VM; Lee EB; Trojanowski JQ
    Acta Neuropathol; 2022 Jan; 143(1):15-31. PubMed ID: 34854996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of cerebral amyloid angiopathy and other co-morbidities in Lewy body diseases.
    Jellinger KA
    J Neural Transm (Vienna); 2021 May; 128(5):687-699. PubMed ID: 33928445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microvascular extracellular matrix in brains with Alzheimer's disease neuropathologic change (ADNC) and cerebral amyloid angiopathy (CAA).
    Damodarasamy M; Vernon RB; Pathan JL; Keene CD; Day AJ; Banks WA; Reed MJ
    Fluids Barriers CNS; 2020 Sep; 17(1):60. PubMed ID: 32993718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer's Disease Dementia: Evidence for Dependency on Alzheimer's Disease Neuropathological Changes.
    Sepulveda-Falla D; Lanau CAV; White C; Serrano GE; Acosta-Uribe J; Mejía-Cupajita B; Villalba-Moreno ND; Lu P; Glatzel M; Kofler JK; Ghetti B; Frosch MP; Restrepo FL; Kosik KS; Beach TG
    medRxiv; 2023 Aug; ():. PubMed ID: 37646002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathological associations of limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) differ between the oldest-old and younger-old.
    Wang SJ; Guo Y; Ervin JF; Lusk JB; Luo S
    Acta Neuropathol; 2022 Jul; 144(1):45-57. PubMed ID: 35551470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing Limbic-Predominant Age-Related TDP-43 Encephalopathy Without Alzheimer's Disease and Lewy Body Dementia in the Oldest Old: A Case Series.
    Leiby AC; Scambray KA; Nguyen HL; Basith F; Fakhraee S; Melikyan ZA; Bukhari SA; Montine TJ; Corrada MM; Kawas CH; Sajjadi SA
    J Alzheimers Dis; 2023; 96(1):113-124. PubMed ID: 37742640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TDP-43 proteinopathy, cerebral amyloid angiopathy, and Lewy bodies with cognitive impairment in individuals with or without Alzheimer's disease neuropathology.
    Thomas DX; Bajaj S; McRae-McKee K; Hadjichrysanthou C; Anderson RM; Collinge J
    Sci Rep; 2020 Sep; 10(1):14579. PubMed ID: 32883971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different curcumin forms selectively bind fibrillar amyloid beta in post mortem Alzheimer's disease brains: Implications for in-vivo diagnostics.
    den Haan J; Morrema THJ; Rozemuller AJ; Bouwman FH; Hoozemans JJM
    Acta Neuropathol Commun; 2018 Aug; 6(1):75. PubMed ID: 30092839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies.
    Maldonado-Díaz C; Hiya S; Yokoda RT; Farrell K; Marx GA; Kauffman J; Daoud EV; Gonzales MM; Parker AS; Canbeldek L; Kulumani Mahadevan LS; Crary JF; White CL; Walker JM; Richardson TE
    Acta Neuropathol; 2024 Mar; 147(1):58. PubMed ID: 38520489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer's disease.
    Walker L; Simpson H; Thomas AJ; Attems J
    Acta Neuropathol Commun; 2024 Feb; 12(1):28. PubMed ID: 38360761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.
    Robinson JL; Lee EB; Xie SX; Rennert L; Suh E; Bredenberg C; Caswell C; Van Deerlin VM; Yan N; Yousef A; Hurtig HI; Siderowf A; Grossman M; McMillan CT; Miller B; Duda JE; Irwin DJ; Wolk D; Elman L; McCluskey L; Chen-Plotkin A; Weintraub D; Arnold SE; Brettschneider J; Lee VM; Trojanowski JQ
    Brain; 2018 Jul; 141(7):2181-2193. PubMed ID: 29878075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method.
    Handa T; Sasaki H; Takao M; Tano M; Uchida Y
    Fluids Barriers CNS; 2022 Jul; 19(1):56. PubMed ID: 35778717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between transactive response DNA-binding protein of 43 kDa type and cognitive resilience to Alzheimer's disease: a case-control study.
    Buciuc M; Whitwell JL; Tosakulwong N; Weigand SD; Murray ME; Boeve BF; Knopman DS; Parisi JE; Petersen RC; Dickson DW; Josephs KA
    Neurobiol Aging; 2020 Aug; 92():92-97. PubMed ID: 32408057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.
    Brenowitz WD; Keene CD; Hawes SE; Hubbard RA; Longstreth WT; Woltjer RL; Crane PK; Larson EB; Kukull WA
    Neurobiol Aging; 2017 May; 53():83-92. PubMed ID: 28236716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.